<SEC-DOCUMENT>0001193125-24-110094-index.html : 20240424
<SEC-HEADER>0001193125-24-110094.hdr.sgml : 20240424
<ACCEPTANCE-DATETIME>20240424161053
ACCESSION NUMBER:		0001193125-24-110094
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240424
DATE AS OF CHANGE:		20240424
EFFECTIVENESS DATE:		20240424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Quince Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001662774
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				901024039
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38890
		FILM NUMBER:		24870687

	BUSINESS ADDRESS:	
		STREET 1:		611 GATEWAY BLVD., SUITE 273
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		415-910-5717

	MAIL ADDRESS:	
		STREET 1:		611 GATEWAY BLVD., SUITE 273
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cortexyme, Inc.
		DATE OF NAME CHANGE:	20160104
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>d790300dars.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: d790300dars.pdf

</DOCUMENT>
</SEC-DOCUMENT>